Bottom line
HGHYX vs FHLC: the short answer
HGHYX (The Hartford Healthcare Fund) and FHLC (Fidelity MSCI Health Care Index ETF) are both mutual funds.
But FHLC is far broader, holding 337 positions to 80 for HGHYX, so beyond the top names it adds exposure HGHYX doesn't have.
FHLC is cheaper at 0.084% vs 1.05% — a difference of $97 a year per $10,000 invested.
Updated Nov 19, 2026
HGHYX vs FHLC side by side
| HGHYX | FHLC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Hartford | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.05% | 0.084% |
| Annual cost per $10k | $105 | $8.4 |
| 10-yr cost on $10k (prospectus) | $1,283 | $108 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | — | +2.6% |
| 5-yr return (annualized) | — | +7.2% |
| 10-yr return (annualized) | — | +8.8% |
| Best quarter | — | +16.4% |
| Worst quarter | — | −13.1% |
| Net assets (fund) | $772.2M | $3.3B |
| Number of holdings | 80 | 337 |
| Portfolio turnover | 49% | 3% |
| Returns as of | — | Nov 30, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
19 of HGHYX's top 25 holdings also appear in FHLC's top 25.
| Holding | HGHYX | FHLC |
|---|---|---|
| Eli Lilly & Co | 12.03% | 13.35% |
| Johnson & Johnson | 6.75% | 8.93% |
| Merck & Co Inc | 6.00% | 4.66% |
| UnitedHealth Group Inc | 4.74% | 5.44% |
| AbbVie Inc | 4.21% | 6.42% |
| Elevance Health Inc | 3.00% | 1.19% |
| Intuitive Surgical Inc | 2.88% | 1.82% |
| CVS Health Corp | 2.84% | 1.92% |
| Vertex Pharmaceuticals Inc | 2.64% | 1.76% |
| Danaher Corp | 2.57% | 1.80% |
| Cencora Inc | 2.46% | 0.83% |
| Regeneron Pharmaceuticals Inc | 2.02% | 1.15% |
| HCA Healthcare Inc | 1.88% | 0.91% |
| Boston Scientific Corp | 1.88% | 1.00% |
| Abbott Laboratories | 1.82% | 2.66% |
Source: SEC Form N-PORT
HGHYX top 10
- Eli Lilly & Co — 12.03%
- Johnson & Johnson — 6.75%
- Merck & Co Inc — 6.00%
- UnitedHealth Group Inc — 4.74%
- AbbVie Inc — 4.21%
- Elevance Health Inc — 3.00%
- Intuitive Surgical Inc — 2.88%
- CVS Health Corp — 2.84%
- Vertex Pharmaceuticals Inc — 2.64%
- Danaher Corp — 2.57%
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
FAQ
What is the difference between HGHYX and FHLC?
Which is cheaper, HGHYX or FHLC?
Should I own both HGHYX and FHLC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.